Biopharma SHAKTI Strategy with ₹10,000 Cr Outlay to Boost Biosimilars Using Non-Animal Methodologies (NAMs)

VP Launches India Valve Registry for Heart Valve Disease Research; TN Reports 2,590 Valve Replacements in 20 Months

The Vice-President launched the India Valve Registry, a first-of-its-kind clinician-led platform to collect real-world data on valvular heart disease and interventions in India. The registry will generate India-specific evidence to improve patient care, while Tamil Nadu's CMCHIS data reveals 2,590 valve replacements in 20 months, highlighting the burden of rheumatic heart disease and the success of state-led healthcare.

National One Health Mission: ICMR Expands Waste-Water Surveillance to 75 Cities by 2027

The National One Health Mission is advancing with waste-water surveillance of 13 priority pathogens across 47 cities, set to expand to 75 cities by 2027. ICMR DG informs Rajya Sabha member about genomic hubs and integrated surveillance, while MHA drafts a National Biosecurity Policy. This is crucial for UPSC prelims (data points, schemes) and mains (health security, One Health approach).

GOBARdhan Scheme Approved with ₹23,731 Cr Outlay to Boost CBG Production Tenfold

Union Cabinet approves GOBARdhan, a National Circular Bioenergy Scheme with ₹23,731 crore outlay for 10 years to increase domestic compressed biogas (CBG) production by nearly 10-fold. The scheme aims to reduce natural gas imports, strengthen energy security, and create a commercially viable waste-to-energy ecosystem through assured offtake, administered pricing, capital subsidies, and pipeline infrastructure.

IN-SPACe Releases Planned Re-entry Guidelines: Safety Threshold 1 in 10,000, Mandates Third-Party Liability Insurance

IN-SPACe has released new guidelines for planned re-entry of space objects, establishing a safety threshold of 1 in 10,000 risk to humans and mandating third-party liability insurance for private operators. This is crucial for India's human spaceflight mission Gaganyaan and the growing private space sector.

India's R&D Spending, Patents Surge but Systemic Barriers Hinder Science Superpower Status: E-book

A Hindu e-book analyzes India's scientific trajectory, noting increased R&D spending and patent filings but flagging critical gaps: poor lab-to-market translation, bureaucratic hurdles, brain drain, and rising pseudoscience. For exams, this is a rich source of 'Challenges to India's Innovation Ecosystem' for GS3.

MeitY Summons Meta Global Team Over Algorithmic Bias; Parliamentary Panel to Question

Government summons Meta's global team to clarify algorithmic bias and role in public order after MeitY rejects technical glitch explanation. Parliamentary panel will also question the company. This highlights growing regulatory scrutiny on social media algorithms and their societal impact.

1,319 AI Employees Sign 'Pacing the Frontier' Letter Urging U.S. Action on AI Safety Regulation

1,319 employees from leading AI companies signed an open letter urging the U.S. government to develop tools to regulate the speed of AI development, triggered by cybersecurity incidents where AI models breached external systems. This reflects the growing tension between rapid AI advancement and safety, and highlights geopolitical competition with China's open-weight models.

NOTTO Reports 20,000+ Transplants in 2025, Launches Portal and Swap Guidelines

NOTTO released 2025 data showing over 20,000 transplants, persistent gender disparity in organ donation (68% female donors vs 78% male recipients), and launched a new digital portal to enhance transparency. New swap transplantation guidelines aim to expand matching beyond single hospitals, but legal recognition under THOTA is still pending.